Genmab A/S (GMAB) Stock Chart & Stock Price History $27.08 +1.19 (+4.60%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$27.08 +0.01 (+0.02%) As of 09/3/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genmab A/S Stock Price Performance The Genmab A/S (GMAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 1.85%, with a year-to-date return of 29.76%. In the past month, the stock has increased 23.20%, reflecting recent market activity. As of the latest close, Genmab A/S traded at $27.08 with a market cap of $17.37 billion and volume of 2.32 million shares. Five years ago, the stock traded at $35.02, representing a 22.67% decrease over that period. At the time, it had a market cap of $24.52 billion and a volume of 907,402 shares. Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+8.89%1 Month Performance+23.20%3 Month Performance+24.33%Year-To-Date Performance+29.76%1 Year Performance-1.85%5 Year Performance-22.67% GMAB Stock Chart for Thursday, September, 4, 2025 GMAB Chart by TradingView Genmab A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/03/2025$25.89$27.08+4.60%$27.16$26.472.32 million shs$17.37 billion09/02/2025$24.87$25.89+4.10%$25.99$25.602.12 million shs$16.61 billion09/01/2025$24.87$24.87$25.00$24.75676,680 shs$15.96 billion08/29/2025$25.11$24.87-0.96%$25.00$24.75676,680 shs$15.96 billion08/28/2025$24.78$25.11+1.33%$25.25$25.012.28 million shs$16.11 billion08/27/2025$24.54$24.78+0.98%$24.93$24.571.18 million shs$15.90 billion08/26/2025$24.31$24.54+0.95%$24.61$24.411.10 million shs$15.74 billion08/25/2025$24.65$24.31-1.38%$24.75$24.281.22 million shs$15.60 billion08/22/2025$24.42$24.65+0.94%$24.84$24.461.39 million shs$15.81 billion08/21/2025$24.06$24.42+1.50%$24.49$24.312.12 million shs$15.67 billion Get the Latest News and Ratings for GMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 08/20/2025$23.82$24.06+1.01%$24.39$24.021.09 million shs$15.44 billion08/19/2025$23.42$23.82+1.71%$23.93$23.621.00 million shs$15.28 billion08/18/2025$23.31$23.42+0.47%$23.59$23.22823,020 shs$15.02 billion08/15/2025$22.98$23.31+1.44%$23.49$23.141.49 million shs$14.95 billion08/14/2025$22.67$22.98+1.37%$23.01$22.48921,349 shs$14.74 billion08/13/2025$21.87$22.67+3.66%$22.69$22.18827,040 shs$14.54 billion08/12/2025$21.08$21.87+3.75%$21.88$21.171.16 million shs$14.03 billion08/11/2025$21.43$21.08-1.63%$21.28$21.00982,925 shs$13.52 billion08/08/2025$22.69$21.43-5.55%$21.66$21.271.75 million shs$13.75 billion08/07/2025$21.51$22.69+5.49%$22.90$21.863.06 million shs$14.56 billion08/06/2025$22.10$21.51-2.67%$21.72$21.381.51 million shs$13.80 billion08/05/2025$21.98$22.10+0.55%$22.27$21.97776,368 shs$14.18 billion08/04/2025$21.78$21.98+0.92%$22.06$21.69967,090 shs$14.10 billion Related Companies Takeda Pharmaceutical Stock Chart argenex Stock Chart BeOne Medicines Stock Chart Insmed Stock Chart BioNTech Stock Chart Teva Pharmaceutical Industries Stock Chart Summit Therapeutics Stock Chart Viatris Stock Chart Ascendis Pharma A/S Stock Chart Dr. Reddy's Laboratories Stock Chart Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMAB) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GMAB Stock Alerts